Veredus Lab announced that the version VEREFLU can detect H7N9 (avian influenza) subtype viruses currently caused by Chinese avian flu. H7N9 is the latest avian influenza gene variation, which has caused widespread concern in the region, and the Chinese government has strengthened the monitoring of avian influenza. The VEREFLU detection system is released in 2008, based on the on-chip laboratory platform of STMic Semiconductors, running on the Veredus Lab VereplextM Biological System, which is the first two powerful molecular biotechnology applications in the market in on-chip laboratory platform, polymerase Flu detection method of chain reaction (PCR) and gene chip.
Be
VEREFLU is a laboratory application on a portable piece that quickly detects all the main influenza types anytime, anywhere. Unlike the existing diagnostic method, VEREFLU is a breakthrough molecular diagnostic detection method, which can detect infectious disease viruses within two hours, and provide relevant gene information, usually take a few days to several Week time. Due to the high degree of automation, medical staff can detect anywhere in the traditional laboratory. In addition to the current H7N9 avian influenza, VEREFLUs have been confirmed to detect and distinguish human A-influenza virus (H1, H3, H5, H7, H9) and viruses, including avian influenza H5N1 subtypes and 2009 popular H1N1 / 2009 subtype virus.
Veredus Lab CEO Rosemary Tan said: "After you know China's explosive bird flu, we confirm through In-Silico [1] test, the current version of the VEREFLU flu detecting system can detect H7N9 subtypes that cause this avian influenza. Virus, as well as human A-type and fluvuses. This confirms the vision of our original design, medical industry needs a multi-gene amplification molecule detection method, which can not only detect ordinary seasonal influenzaic viruses, but also It is detected that new subtype viruses, including current popular H7N9 subtype avian influenza viruses that can be infected by animals to humans. .Verteflu can help our customers detect H7N9 viruses and immediately provide a quick and reliable that can be deployed to on-site monitoring Monitoring system. "
About Veredus Laboratory Private Co., Ltd.
Veredus Laboratory Private Co., Ltd. was established in 2003 and launched the first product in 2005. The Veredus Labs is a subsidiary of STMicroe with most equity in Singapore. STMicroe is a global semiconductor supplier (StMicroelectronics, referral to ST; New York Stock Exchange Code: STM).
Veredus specializes in developing and selling innovative multiplexed molecular diagnostic solutions, the target market includes clinical, special and custom test markets, which are based on the unique laboratory platform of simple semiconductors. The trademark of the on-chip laboratory platform is a VereplextM biological system, which uses a microelectromechanical system (MEMS) and microjet technology, integrated multiplexed DNA amplifier circuits and gene chips, and can accurately analyze biological materials quickly, economically and accurately. Technology area
Molex Interconnect Solution For Persistence Durable Medical I / O Apps
How far is the era of Ai + medical treatment?
China-US union sniper cancer cell DNA nano machine
Artificial intelligence to overcome 42 medical experts experts will face unemployment?
Chinese scholars rely on the "Heart Chip" for the first time, "scientific robot"
Our other product:
